PSC
ZBH icon

Prentiss Smith & Co’s Zimmer Biomet ZBH Stock Holding History

Prentiss Smith & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-104
Closed -$13K – 236
2018
Q3 		$13K Hold
104
– – 0.01% 192
2018
Q2 		$11K Hold
104
– – 0.01% 203
2018
Q1 		$11K Buy
+104
New +$12.1K 0.01% 215

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prentiss Smith & Co's ZBH Position: Q4 2018 in Review

Prentiss Smith & Co sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 104 shares — an estimated $13K sold.

Prentiss Smith & Co first reported a position in ZBH in Q1 2018 and held it in 3 quarters. The position peaked at $13K in Q3 2018. 871 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • Prentiss Smith & Co reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
  • Prentiss Smith & Co sold 104 Zimmer Biomet shares in Q4 2018, an estimated $13K.
  • Prentiss Smith & Co first reported a position in Zimmer Biomet in Q1 2018 and held it in 3 quarters.
  • Prentiss Smith & Co's Zimmer Biomet position peaked at $13K in Q3 2018.
  • 871 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Prentiss Smith & Co's 13F filing for Q4 2018, filed 15 Jan 2019.